HitGen Inc. logo —  Novel Molecules for Innovative Medicines

HitGen Inc.

Novel Molecules for Innovative Medicines

Founded 2012 China Chengdu, China 85 employees Series B Biotechnology, Health Care

General Information

Company Name HitGen Inc.
Founded Year 2012
Location China Chengdu, China +1
Employees 85
Industries Biotechnology, Health Care
Funding Stage Series B
Social

Get notified when HitGen Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About HitGen Inc.

HitGen Inc. is a biopharmaceutical company headquartered in Chengdu, China, with subsidiaries in Cambridge, UK and Houston, USA. Established in 2012, the company is dedicated to the discovery and optimization of small molecules and nucleic acid drugs. HitGen focuses on building an internationally leading drug discovery and optimization system, with a strong emphasis on DNA-encoded library technology (DEL), fragment-based drug discovery and structure-based drug design technologies (FBDD/SBDD), synthetic therapeutic oligonucleotide technology (STO), and targeted protein degradation technology (TPD). The company offers new molecular entities at various stages of research and development for the pharmaceutical industry through diverse business models, including research and development services, out-licensing of projects, and new drug launches. It currently has approximately 20 in-house drug discovery projects at different stages, with 4 having obtained IND approvals and entered clinical trials. HitGen collaborates with pharmaceutical, biotech, and chemical companies, as well as foundations and research institutes across the Americas, Asia, Europe, Africa, and Oceania. As a pioneer in the field of DEL technology, HitGen has been committed to the development, application, and improvement of DEL technology since its establishment in 2012. For further information, please contact +86-28-85197385 or +1-508-840-9646, or visit www.hitgen.com. For business development inquiries, email [email protected].

No funding data available for HitGen Inc. yet.

Get notified when HitGen Inc. raises funding

HitGen Inc. Alternatives & Competitors

HitGen Inc. vs

Source of Innovative Preclinical Therapeutic Leads for partnering or full out-licensing & IP assignm...

8 employees
Biotechnology, Health Care
HitGen Inc. vs

Small Molecule CRO/CDMO Service Provider

35 employees
Manufacturing, Pharmaceutical
HitGen Inc. vs
Denovo Biopharma
Denovo Biopharma United States

A Novel Biomarker Discovery Solution for Personalized Drug Development Denovo Biopharma is a priva...

Grant
29 employees
Biopharma, Biotechnology

FAQ About HitGen Inc.

Novel Molecules for Innovative Medicines
HitGen Inc. was founded in 2012.
HitGen Inc. is headquartered in Chengdu, China.
HitGen Inc. operates in the following industries: Biotechnology, Health Care.
HitGen Inc. has approximately 85 employees.
Top alternatives and competitors to HitGen Inc. include Hager Biosciences, LLC, PharmaResources, Denovo Biopharma, Spark Biopharma, BeBetter Med. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
HitGen Inc. and Hager Biosciences, LLC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors HitGen Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy